Find information on thousands of medical conditions and prescription drugs.

Docusate sodium

Docusate (DAH cue sate) is the generic name of a surfactant used as a laxative and stool softener, which is sold in the U.S. under multiple brand names: Aqualax, Calube, Colace, Colace Micro-Enema, Correctol Softgel Extra Gentle, DC-240, Dialose, Diocto, Dioctocal, Dioctosoftez, Dioctyn, Dionex, Doc-Q-Lace, Docu Soft, Docucal, Doculax, Docusoft S, DOK, DOS, Doss-Relief, DSS, Ex-Lax Stool Softener, Fleet Sof-Lax, Genasoft, Kasof, Modane Soft, Octycine-100, Regulax SS, Sulfalax Calcium, Sur-Q-Lax, Surfak Stool Softener and Therevac-SB. more...

Home
Diseases
Medicines
A
B
C
D
Dacarbazine
Dactinomycin
Dalmane
Danazol
Dantrolene
Dapoxetine
Dapsone
Daptomycin
Daraprim
Darvocet
Darvon
Daunorubicin
Daunorubicin
Daypro
DDAVP
Deca-Durabolin
Deferoxamine
Delsym
Demeclocycline
Demeclocycline
Demerol
Demulen
Denatonium
Depakene
Depakote
Depo-Provera
Desferal
Desflurane
Desipramine
Desmopressin
Desogen
Desogestrel
Desonide
Desoxyn
Desyrel
Detrol
Dexacort
Dexamethasone
Dexamfetamine
Dexedrine
Dexpanthenol
Dextran
Dextromethorphan
Dextromoramide
Dextropropoxyphene
Dextrorphan
Diabeta
Diacerein
Diacetolol
Dial
Diamox
Diazepam
Diazoxide
Dibenzepin
Diclofenac
Diclohexal
Didanosine
Dieldrin
Diethylcarbamazine
Diethylstilbestrol
Diethyltoluamide
Differin
Diflucan
Diflunisal
Digitoxin
Digoxin
Dihydrocodeine
Dihydroergotamine
Dihydrotachysterol
Dilantin
Dilaudid
Diltahexal
Diltiazem
Dimenhydrinate
Dimercaprol
Dimetapp
Dimethyl sulfoxide
Dimethyltryptamine
Dimetridazole
Diminazene
Diovan
Dioxybenzone
Diphenhydramine
Diphenoxylate
Dipipanone
Dipivefrine
Diprivan
Diprolene
Diproteverine
Dipyridamole
Disulfiram
Disulfiram
Dizocilpine
Dobutamine
Docetaxel
Docusate sodium
Dofetilide
Dolasetron
Dolobid
Dolophine
Domperidone
Donepezil
Dopamine
Dopram
Doral
Doramectin
Doriden
Dornase alfa
Doryx
Dostinex
Doxapram
Doxazosin
Doxepin
Doxil
Doxil
Doxorubicin
Doxy
Doxycycline
Doxyhexal
Doxylamine
Drisdol
Drixoral
Dronabinol
Droperidol
Drospirenone
Duloxetine
Durabolin
Duragesic
Duraphyl
Duraquin
Dutasteride
Dv
Dyclonine
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Docusate is also any of a group of anionic surfactants widely used as emulsifying, wetting, and dispersing agents.

Clinical use

Docusate is given to make stools softer and easier to pass. It is used to treat constipation due to hard stools, in painful anorectal conditions such as hemorroids, and for people who should avoid straining during bowel movements. Of note is that that effect of docusate may not necessarily be all due to its surfactant properties. Perfusion studies suggest that docusates inhibit fluid absorption or stimulate secretion in jejunum.

While the use of docusate is widespread, the data to support its efficacy in treating chronic constipation is actually lacking. Although more research is needed, long term use of docusate seems to decrease levels of magnesium and potassium in the blood.

Presentations

  • Docusate is available in tablet, capsule, liquid and rectal enema.
  • Docusate calcium and docusate potassium are anionic surfactants used as stool softeners and are administered orally.
  • Docusate sodium is anionic surfactant used as a stool softener and is administered orally or rectally; as a tablet disintegrant or as an emulsifier and dispersant in topical preparations. When sold as Colace, it is docusate sodium, or sodium salt of dioctyl sodium sulfosuccinate (DSS). Some metabolism studies show that DSS is absorbed by the body from the gastrointestinal tract, undergoing extensive metabolism. In humans, the main way DSS metabolites are extreted is via the feces.

Effect

  • The effect on stools is seen 1 to 3 days after the first dose.

Read more at Wikipedia.org


[List your site here Free!]


What is the best way to remove cerumen in children?
From American Family Physician, 7/1/04 by Karl E. Miller

In children, obstruction of the ear canal with cerumen can make visualization of the tympanic membrane difficult, if not impossible. This can cause a significant problem with the examination of children with febrile ill-nesses. In addition, cerumen impaction can cause ear canal irritation and hearing loss. Various methods are used to remove cerumen, including irrigation, suction, and manual removal with a curette. Several studies have assessed the effectiveness of softening the cerumen with agents such as olive oil, sodium bicarbonate, docusate sodium, para dichlorobenzene, hydrogen peroxide, and triethanolamine polypeptide. Most of these studies were limited by lack of a comparison group or by enrolling only a few children. Whatley and colleagues evaluated the efficacy of docusate sodium, triethanolamine polypeptide, and normal saline as a control, with or without irrigation, in removing cerumen obstruction in children.

The study was a randomized, controlled, double-blind trial of pediatric patients with cerumen obstruction. The participants were children six months to five years of age who were seen in an urban tertiary care emergency department or a large general pediatric clinic. Obstruction of the ear canal with cerumen was identified as partial or complete by one of the four investigators. The children were randomized to receive 1 mL of docusate sodium, triethanolamine polypeptide, or normal saline in the ear canal. If the physician was unable to completely visualize the tympanic membrane 15 minutes later, the ear was irrigated with 50 mL of tepid water. This step was repeated if the membrane was still obstructed. The main outcome measurement was the proportion of tympanic membranes that were completely visualized after the initial treatment or after irrigation.

There were 92 patients enrolled in the study, with a mean age of 35 months. The three treatment groups were similar with regard to age, race, sex, ear enrolled, wax consistency (soft, hard, or mixed), and degree of obstruction. Complete visualization of the tympanic membrane was achieved after treatment in 53 percent of children treated with docusate sodium, 43 percent of children treated with triethanolamine polypeptide, and 68 percent of children treated with normal saline. These results were not significantly different.

There was no difference in response rates when the study site or the investigators were compared. The only trend noted was a higher success rate if the cerumen was considered to be soft rather than hard or mixed. The only adverse event recorded was minor ear canal bleeding after irrigation in one child.

The authors conclude that the use of docusate sodium or triethanolamine polypeptide, compared with the use of normal saline, does not increase the likelihood of visualizing tympanic membranes that were obstructed with cerumen. They add that, despite recent recommendations for the use of docusate sodium before ear irrigation, their findings suggest that this agent is no more effective than saline in children six months to five years of age.

KARL E. MILLER, M.D. Whatley VN, et al. Randomized clinical trial of docusate, triethanolamine polypeptide, and irrigation in cerumen removal in children. Arch Pediatr Adolesc Med December 2003;157:1177-80.

COPYRIGHT 2004 American Academy of Family Physicians
COPYRIGHT 2004 Gale Group

Return to Docusate sodium
Home Contact Resources Exchange Links ebay